An Analytical Reference Standard
Features
  • This product has been formulated as an exempt preparation which meets criteria established by the US DEA
  • Possession of a DEA Controlled Substance registration is not necessary nor is a DEA 222 form required to purchase this product
  • This product is intended to be used as an analytical reference standard
  • Bulk material is available for academic research at qualified institutions; please contact our sales department for pricing
Related Products
Alternative(s)
19858MAB-CHMINACA-d4 (CRM)
Non-Exempt Preparation(s)
18878MAB-CHMINACA-d4
Unlabeled Version(s)
16616MAB-CHMINACA 22047MAB-CHMINACA (CRM)
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

MAB-CHMINACA-d4 (exempt preparation)

Item No. 46411

Exempt Product (US)
Product Insert (PDF)
Synonyms
Synonyms
  • ADB-CHMINACA-d4
Technical Information
Formal Name
N-[1-(aminocarbonyl)-2,2-dimethylpropyl]-1-(cyclohexylmethyl)-1H-indazole-d4-3-carboxamide
CAS Number
2747913-91-1
Molecular Formula
C21H26D4N4O2
Formula Weight
374.5
Purity
≥99% deuterated forms (d1-d4)
Formulation (Request formulation change)
A 100 µg/ml solution in methanol
SMILES
O=C(NC(C(N)=O)C(C)(C)C)C1=NN(CC2CCCCC2)C3=C1C([2H])=C([2H])C([2H])=C3[2H]
InChi Code
InChI=1S/C21H30N4O2/c1-21(2,3)18(19(22)26)23-20(27)17-15-11-7-8-12-16(15)25(24-17)13-14-9-5-4-6-10-14/h7-8,11-12,14,18H,4-6,9-10,13H2,1-3H3,(H2,22,26)(H,23,27)/i7D,8D,11D,12D
InChi Key
ZWCCSIUBHCZKOY-CXRURWBMSA-N
Regulatory Information
DEA Exempt Notification
This product is a DEA exempt preparation of a scheduled compound - does not require DEA Controlled Substance registration or DEA 222 form. For alternate sizes please contact sales.
Shipping & Storage Information
Storage
-20°C
Shipping
Wet ice in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    100 µg

    $149

    Add
    Cayman Chemical
    Cayman Spectral Library

    Our free, searchable, GC-MS spectral database contains 70eV EI mass spectral data of 2,000+ of Cayman’s forensic drug standards.

    DOWNLOAD THE DATABASE
    Product Description

    MAB-CHMINACA-d4 (exempt preparation) (Item No. 46411) is intended for use as an internal standard for the quantification of MAB-CHMINACA (Item Nos. 22047 | 16616) by GC- or LC-MS. MAB-CHMINACA is categorized as a synthetic cannabinoid.1,2 It has been found in herbal blend products and has been involved in at least one case of fatal overdose.3,4 MAB-CHMINACA-d4 is regulated as a Schedule I compound in the United States. MAB-CHMINACA-d4 (exempt preparation) (Item No. 46411) is provided as a DEA exempt preparation. This product is intended for research and forensic applications.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Buchler, I.P., Hayes, M.J., Hedge, S.G., et al. Indazole derivatives. 1-283 (2009).

    2. Carlier, J., Diao, X., Sempio, C., et al. Identification of new synthetic cannabinoid ADB-CHMINACA (MAB-CHMINACA) metabolites in human hepatocytes. AAPS J. 19(2), 568-577 (2017).

    3. Hasegawa, K., Wurita, A., Minakata, K., et al. Postmortem distribution of MAB-CHMINACA in body fluids and solid tissues of a human cadaver. Forensic Toxicol. 33(2), 380-387 (2015).

    4. Adamowicz, P., and Gieroń, J. Acute intoxication of four individuals following use of the synthetic cannabinoid MAB-CHMINACA. Clin. Toxicol. (Phila) 54(8), 650-654 (2016).